HIGHLIGHTS
- who: Recurrent Glioblastoma Multiforme et al. from the Department of Neurology, Xuzhou Center Hospital, Xuzhou, China Department of Cancer, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology have published the Article: Retrospective Analysis of Bevacizumab in Combination with Fotemustine in Chinese Patients with Recurrent Glioblastoma Multiforme, in the Journal: (JOURNAL) of 22/01/2015
- what: The aim of this study was to assess the activity and safety of bevacizumab (BEV) and fotemustine (FTM) for the treatment of_(GBM) patients and explore the potential prognostic parameters on survival. It should be noted that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.